Metraipolis › archive › dc_edec71d5032c

A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer — Europe PMC PMID:41306526

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41306526
DOI
10.3389/fonc.2025.1693277
License (as archived)
solo-consultazione
Archived
2026-11-08T15:56:55.012Z
SHA-256 of the archived text
aaf4f94d3b5ab40d27cd35b4e255374a9cfd630142e9df414d8719241d877998
Stable URL of this page
https://metraipolis.com/documento/dc_edec71d5032c

How to cite

A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer — Europe PMC PMID:41306526 — Europe PMC (en), https://europepmc.org/article/MED/41306526 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_edec71d5032c (Metraipolis archive dc_edec71d5032c, sha256 aaf4f94d3b5ab40d27cd35b4e255374a9cfd630142e9df414d8719241d877998)
BibTeX
@misc{dcedec71d5032c,
  title = {A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer — Europe PMC PMID:41306526},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41306526},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_edec71d5032c; sha256 aaf4f94d3b5ab40d27cd35b4e255374a9cfd630142e9df414d8719241d877998},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41306526. Agents can read the archived copy with the MCP tool read_document.